Inhibitor of apoptosis protein (IAP) antagonists in anticancer agent discovery: Current status and perspectives

H Cong, L Xu, Y Wu, Z Qu, T Bian… - Journal of Medicinal …, 2019 - ACS Publications
Apoptosis, an important form of programmed cell death (PCD), is a tightly regulated cellular
process to eliminate unwanted or damaged cells. Resistance of apoptosis is a hallmark of …

Bivalent SMAC mimetics for treating cancer by antagonizing inhibitor of apoptosis proteins

H Zhu, Y Li, Y Liu, B Han - ChemMedChem, 2019 - Wiley Online Library
Inhibitors of apoptosis proteins (IAPs) inhibit caspase activity, allowing various cancers to
reduce programmed cell death (apoptosis) and resist drug treatment. The second …

Changing the apoptosis pathway through evolutionary protein design

D Shultis, P Mitra, X Huang, J Johnson… - Journal of molecular …, 2019 - Elsevier
One obstacle in de novo protein design is the vast sequence space that needs to be
searched through to obtain functional proteins. We developed a new method using structural …

Development of XIAP antagonists based on de novo 8, 5‐fused bicyclic lactams

ZJ Sheng, YM Shi, X Xu, S Bellynck, K Zhang… - …, 2019 - Wiley Online Library
In order to develop original water soluble antagonists of X‐linked inhibitor of apoptosis
protein (XIAP), a novel bicyclic scaffold was designed based on 8, 5‐fused bicyclic lactam …

Apoptosis-inducing Factor Mediates Metabolism and Oxidative Stress Signaling Through Functionally Uncoupled Mechanisms to the Benefit of Tumorigenesis

AJ Scott - 2019 - search.proquest.com
Cancer is one of the leading causes of death in the world, arising when cells accumulate
genomic mutations that render them incapable of controlling their own proliferation and …